| Title |
|
|
|
Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
European journal of obstetrics and gynecology and reproductive biology. - Amsterdam | |
| Publication |
|
|
|
Amsterdam : 2018
| |
| ISSN |
|
|
|
0301-2115
| |
| Volume/pages |
|
|
|
221(2018), p. 46-51
| |
| ISI |
|
|
|
000429185900009
| |
| Pubmed ID |
|
|
|
29245056
| |
| Full text (Publisher's DOI) |
|
|
| | |
|